We are live on
!
Find out more
FG
Formula Growth Portfolio holdings
AUM
$222M
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+15.49%
1 Year Est. Return
+27.84%
3 Year Est. Return
+65.65%
5 Year Est. Return
+39.07%
10 Year Est. Return
+165.6%
AUM
$265M
AUM Growth
+$18.1M
(+7.4%)
Cap. Flow
-$11.1M
Cap. Flow
% of AUM
-4.2%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
141
New
23
Increased
19
Reduced
54
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
James Hardie Industries
JHX
|
+$5.32M |
| 2 |
Lantheus
LNTH
|
+$2.29M |
| 3 |
TAT Technologies
TATT
|
+$2.01M |
| 4 |
UnitedHealth
UNH
|
+$1.84M |
| 5 |
PRO
PROS Holdings
PRO
|
+$1.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wayfair
W
|
+$5.04M |
| 2 |
PagSeguro Digital
PAGS
|
+$2.96M |
| 3 |
Palomar
PLMR
|
+$2.84M |
| 4 |
Calix
CALX
|
+$2.57M |
| 5 |
Orion Group Holdings
ORN
|
+$2.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.15% |
| 2 | Industrials | 19.46% |
| 3 | Healthcare | 18.14% |
| 4 | Consumer Discretionary | 16.63% |
| 5 | Financials | 4.74% |
Similar funds
BOCM
DFG
CFGF
AWM
PLC
EMCIP
BP
SAM
Formula Growth's Q2 2025 Portfolio in Review
As of Q2 2025, Formula Growth held 141 positions worth $265M, up 7.4% from $247M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Formula Growth withdrew a net $11.1M in Q2 2025, closing 22 positions and reducing 54 holdings. Its most notable exit was Eli Lilly, an estimated $2.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Formula Growth opened a new position in James Hardie Industries worth $5.92M.
- Formula Growth's largest Q2 2025 buy was James Hardie Industries: 220,140 shares worth $5.92M.
- Formula Growth added most to Tutor Perini Cor in Q2 2025, an estimated $1.54M increase.
- Formula Growth's biggest Q2 2025 reduction was Wayfair, cutting an estimated $5.04M.
- Formula Growth fully exited Eli Lilly in Q2 2025, selling an estimated $2.2M.
- Formula Growth's ten largest holdings make up 22% of its $265M portfolio in Q2 2025.
- Formula Growth opened 23 new positions and closed 22 in Q2 2025.
- Formula Growth's portfolio value rose 7.4% quarter-over-quarter to $265M.
Based on Formula Growth's 13F filing for Q2 2025, filed 13 Aug 2025.